Paclitaxel CAS 33069-62-4 Anticancer GMP yemerewe gukora paclitaxel

Ibisobanuro bigufi:

Paclitaxel ni metabolite isanzwe ya kabiri yitaruye kandi yezwa mubishishwa bya kanseri yimitsi ya gymnosperm.Amashami n'ibibabi bikoreshwa mu kuvura indwara ya leukemia, nephritis, diyabete, n'indwara y'impyiko.Paclitaxel niwo muti wa antikanseri uzwi cyane mu myaka yashize kandi ufatwa nk'umwe mu miti igabanya ubukana mu myaka 20 iri imbere.


Ibicuruzwa birambuye

Ibicuruzwa

Amakuru y'ibicuruzwa

Izina:Kamere Kamere

Numero ya CAS:33069-62-4

Imiti yimiti:C47H51NO14

Ibisobanuro:99% -102%

Ibara:ifu yera cyangwa hafi yera

Inkomoko:Tagisi yunnanensis, Tagisi chinensis

Ubwoko:APIs

Hande umusaruro cycle & ubushobozi

Inzira y'ibicuruzwa:Iminsi 45

Ubushobozi bwo gutanga umusaruro:500kg / umwaka

Amateka ya Hande GMP

1. Muri 1996, hashyizweho sisitemu yubuziranenge kandi ibona DMF.

2. Muri 2004, FDA ku igenzura yabonye icyemezo cya CGMP.

3. Muri 2009, habonetse igice cya sintetike paclitaxel DMF na paclitaxel naturel ya CEP.

4. Muri 2011, igice cya sintetike paclitaxel CEP cyabonetse.

5. Muri 2012, yatsinze TGA ubugenzuzi ku rubuga, abona icyemezo cya GMP, anatsinda FDA ku igenzura.

6. Muri 2013, yatsinze urubuga rwa CGMP.

7. Muri 2015, Ubuhinde bwaranditswe, Ubuyapani bwandikwa.

Serivisi zacu

1.Ibicuruzwa:Tanga ibihingwa byujuje ubuziranenge, bifite isuku nyinshi, ibikoresho bya farumasi, hamwe naba farumasi.

2.Serivisi za tekiniki:Ibicuruzwa byabigenewe bifite ibisobanuro byihariye ukurikije ibyo umukiriya asabwa.

Uruganda

Ba umutanga mwiza wibikoresho fatizo ninganda zifite ubunyangamugayo!

Murakaza neza kundeba mwohereza imeri kurimarketing@handebio.com


  • Mbere:
  • Ibikurikira: